GE HealthCare Technologies (GEHC) Cost of Revenue (2022 - 2026)

GE HealthCare Technologies has reported Cost of Revenue for 5 years, with the latest figure at $481.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 19.57% year-over-year to $481.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 billion (up 251.93% YoY), and the FY2025 full-year result was $3.4 billion, up 78.03% from the prior year.
• Cost of Revenue for Q1 2026 stood at $481.0 million, down from $887.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $2.1 billion in Q3 2023, with the low at -$5.0 billion in Q4 2023.
• Historically, Cost of Revenue has averaged $12.5 million across 5 years, with a median of $751.0 million in 2022.
• Annual changes were most pronounced in 2024 — Cost of Revenue tumbled 60.4% — and 2025, when it jumped 121.56%.
• GE HealthCare Technologies' Cost of Revenue stood at -$3.4 billion in 2022, then tumbled by 49.27% to -$5.0 billion in 2023, then grew by 17.78% to -$4.1 billion in 2024, then jumped by 121.56% to $887.0 million in 2025, then tumbled by 45.77% to $481.0 million in 2026.
• The last three Cost of Revenue figures came in at $481.0 million (Q1 2026), $887.0 million (Q4 2025), and $884.0 million (Q3 2025), per Business Quant data.